MacroGenics (MGNX)
(Real Time Quote from BATS)
$3.49 USD
-0.34 (-8.88%)
Updated Aug 5, 2024 10:10 AM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MGNX 3.49 -0.34(-8.88%)
Will MGNX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MGNX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MGNX
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates
MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates
MGNX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out for
Lantheus Holdings (LNTH) Q4 Earnings and Revenues Beat Estimates
MacroGenics (MGNX) Surges 6.8%: Is This an Indication of Further Gains?
Other News for MGNX
MacroGenics: A Strong Buy on Robust Pipeline and Financial Stability
MacroGenics crashes as trial update leads to downgrades
Match Group Layoffs 2024: What to Know About the Latest MTCH Job Cuts
MacroGenics (MGNX) Gets a Buy from Evercore ISI
Why is Macrogenics (MGNX) Stock Down 28% Today?